Jeffrey Trigilio - Net Worth and Insider Trading

Jeffrey Trigilio Net Worth

The estimated net worth of Jeffrey Trigilio is at least $2 Million dollars as of 2024-05-05. Jeffrey Trigilio is the CFO of Cullinan Therapeutics Inc and owns about 83,919 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $2 Million. Details can be seen in Jeffrey Trigilio's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey Trigilio has not made any transactions after 2023-12-21 and currently still holds the listed stock(s).

Transaction Summary of Jeffrey Trigilio

To

Jeffrey Trigilio Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Trigilio owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .

Click here to see the complete history of Jeffrey Trigilio’s form 4 insider trades.

Insider Ownership Summary of Jeffrey Trigilio

Ticker Comapny Transaction Date Type of Owner
CGEM Cullinan Therapeutics Inc 2023-12-21 Chief Financial Officer

Jeffrey Trigilio Latest Holdings Summary

Jeffrey Trigilio currently owns a total of 1 stock. Jeffrey Trigilio owns 83,919 shares of Cullinan Therapeutics Inc (CGEM) as of December 21, 2023, with a value of $2 Million.

Latest Holdings of Jeffrey Trigilio

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CGEM Cullinan Therapeutics Inc 2023-12-21 83,919 28.35 2,379,104

Holding Weightings of Jeffrey Trigilio


Jeffrey Trigilio Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeffrey Trigilio has made a total of 13 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 12 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 1,920 shares on December 21, 2023, which brought Jeffrey Trigilio around $16,320.

Insider Trading History of Jeffrey Trigilio

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeffrey Trigilio Trading Performance

GuruFocus tracks the stock performance after each of Jeffrey Trigilio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Trigilio is 0.95%. GuruFocus also compares Jeffrey Trigilio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Trigilio within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeffrey Trigilio's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeffrey Trigilio

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 35.18
Relative Return to S&P 500(%) 31.66

Jeffrey Trigilio Ownership Network

Ownership Network List of Jeffrey Trigilio

No Data

Ownership Network Relation of Jeffrey Trigilio


Jeffrey Trigilio Owned Company Details

What does Cullinan Therapeutics Inc do?

Who are the key executives at Cullinan Therapeutics Inc?

Jeffrey Trigilio is the Chief Financial Officer of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include Acting Chief Business Officer Savill Corrine , director & President and CEO Nadim Ahmed , and Chief Legal Officer Jacquelyn L Sumer .

Cullinan Therapeutics Inc (CGEM) Insider Trades Summary

Over the past 18 months, Jeffrey Trigilio made 10 insider transaction in Cullinan Therapeutics Inc (CGEM) with a net sale of 6,823. Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 19,949 shares made by Jennifer Michaelson , a net sale of 3,809 shares made by Jeffrey Alan Jones , and a net sale of 2,867 shares made by Jacquelyn L Sumer .

In summary, during the past 3 months, insiders sold 0 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 160,608 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 160,608 shares.

Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cullinan Therapeutics Inc Insider Transactions

No Available Data

Jeffrey Trigilio Mailing Address

Above is the net worth, insider trading, and ownership report for Jeffrey Trigilio. You might contact Jeffrey Trigilio via mailing address: C/o Cullinan Management, Inc., One Main Street, Sutie 520, Cambridge Ma 02142.

Discussions on Jeffrey Trigilio

No discussions yet.